JACOBS LEVY EQUITY MANAGEMENT, INC – Travere Therapeutics, Inc. Transaction History
JACOBS LEVY EQUITY MANAGEMENT, INC portfolio value:
$17.94M
portfolio value
JACOBS LEVY EQUITY MANAGEMENT, INC quarter portfolio value change:
+1.69%
quarter
Travere Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +30.51% | 170.21K shares | 4.42M | $24.64 | 728.11K |
Q2 2022 | share | Decrease | -39.72% | -367.54K shares | -10.33M | $24.23 | 557.90K |
Q1 2022 | share | Decrease | -1.45% | -13.64K shares | -5.3M | $25.77 | 925.44K |
Q4 2021 | share | Decrease | -9.04% | -93.30K shares | 4.11M | $30.31 | 939.09K |
Q3 2021 | share | Increase | +30.53% | 241.46K shares | 13.49M | $24.25 | 1.03M |
Q2 2021 | share | Increase | +23.36% | 149.75K shares | -4.47M | $14.59 | 790.93K |
Q1 2021 | share | Decrease | -0.76% | -4.87K shares | -1.59M | $24.97 | 641.17K |
Q4 2020 | share | Increase | 0.00% | 646.05K shares | 17.60M | $27.26 | 646.05K |